From The Team

The number of youth receiving medicine for emotional and mental health in Aotearoa New Zealand has increased relative to previous years. Perhaps even more concerning, is the widening of the gap in prescribing to rangatahi Māori and young Pacific peoples compared to their peers of European/Other ethnicity.

Find out more in this press release. 

Contributor
He Ako Hiringa

Our June newsletter features our youth mental health reflection activity and our upcoming webinar with Drs Cathy Stephenson and Arran Culver. It also highlights our free EPiC training sessions and resources about immune checkpoint inhibitors, triazolam, and ADHD medicine changes.

Read the newsletter here.

Data reviewed by He Ako Hiringa suggest that 70,000 patients were still being dispensed cilazapril as at the end of May 2023. This ACE inhibitor is set to be delisted by the end of the year. Consider changing patients to another medicine now, to ensure a smooth pre-Christmas transition.

Find out more in this press release.

Contributor
He Ako Hiringa

It's been a huge year for us, and we've been so grateful for your support. In our December newsletter we revisit our most popular resources from the year, outline what you can expect from us in 2023, and provide you with updates from our sector relationship manager. 

Read the newsletter here.